Emmaus Life Sciences Reports Third Quarter Financial Results and Business Highlights

TORRANCE, Calif.: TORRANCE, Calif., Nov. 12, 2021 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported financial results for the quarter and nine months ended September 30, 2021. Recent Highlights November: Formed a partnership with UpScript...

Click to view original post